MeSH Review:
Liver Cirrhosis, Experimental
- Atrial natriuretic peptide: renal effects in cirrhosis of the liver. Levy, M. Semin. Nephrol. (1997)
- Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Rudolph, K.L., Chang, S., Millard, M., Schreiber-Agus, N., DePinho, R.A. Science (2000)
- Melatonin prevents experimental liver cirrhosis induced by thioacetamide in rats. Cruz, A., Padillo, F.J., Torres, E., Navarrete, C.M., Muñoz-Castañeda, J.R., Caballero, F.J., Briceño, J., Marchal, T., Túnez, I., Montilla, P., Pera, C., Muntané, J. J. Pineal Res. (2005)
- Enhanced synthesis and reduced metabolism of endothelin-1 (ET-1) by hepatocytes--an important mechanism of increased endogenous levels of ET-1 in liver cirrhosis. Kuddus, R.H., Nalesnik, M.A., Subbotin, V.M., Rao, A.S., Gandhi, C.R. J. Hepatol. (2000)
- Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats. Tsuboi, Y., Ishikawa, S., Fujisawa, G., Okada, K., Saito, T. Kidney Int. (1994)
- Role of the heme oxygenases in abnormalities of the mesenteric circulation in cirrhotic rats. Sacerdoti, D., Abraham, N.G., Oyekan, A.O., Yang, L., Gatta, A., McGiff, J.C. J. Pharmacol. Exp. Ther. (2004)
- Elevated serum dipeptidyl peptidase IV (CD26, EC 3.4.14.5) activity in experimental liver cirrhosis. Lakatos, P.L., Firneisz, G., Borcsiczky, D., Zalatnai, A., Selmeci, L., Szalay, F. Eur. J. Clin. Invest. (2000)
- Hemodynamic characterization in experimental liver cirrhosis induced by thioacetamide administration. Hori, N., Okanoue, T., Sawa, Y., Mori, T., Kashima, K. Dig. Dis. Sci. (1993)
- Role of prostaglandins and thromboxane in the control of renal hemodynamics in experimental liver cirrhosis. Leehey, D.J., Uckerman, M.T., Rahman, M.A. J. Lab. Clin. Med. (1989)
- The influence of an experimental liver cirrhosis upon the metabolism of diazepam and imipramine hydrochloride in the rat. Trennery, P.N., Waring, R.H. Xenobiotica (1985)
- Serum amino acid changes in rats with thioacetamide-induced liver cirrhosis. Fontana, L., Moreira, E., Torres, M.I., Fernández, M.I., Ríos, A., Sánchez de Medina, F., Gil, A. Toxicology (1996)
- Methylthioadenosine phosphorylase gene expression is impaired in human liver cirrhosis and hepatocarcinoma. Berasain, C., Hevia, H., Fernández-Irigoyen, J., Larrea, E., Caballería, J., Mato, J.M., Prieto, J., Corrales, F.J., García-Trevijano, E.R., Avila, M.A. Biochim. Biophys. Acta (2004)
- Renal endothelin system in rats with liver cirrhosis. Hocher, B., Zart, R., Diekmann, F., Gross, P., Distler, A., Bauer, C. J. Cardiovasc. Pharmacol. (1995)
- Expression and distribution of the prolactin receptor in normal rat liver and in experimental liver cirrhosis. Kloehn, S., Otte, C., Korsanke, M., Arendt, T., Clemens, A., Glasow, A., Bornstein, S.R., Fölsch, U.R., Mönig, H. Horm. Metab. Res. (2001)
- Antioxidant effects of insulin-like growth factor-I (IGF-I) in rats with advanced liver cirrhosis. García-Fernández, M., Castilla-Cortázar, I., Díaz-Sanchez, M., Navarro, I., Puche, J.E., Castilla, A., Casares, A.D., Clavijo, E., González-Barón, S. BMC gastroenterology [electronic resource]. (2005)